This chapter summarizes the topics covered in the book.
research and development
This book takes a theory-to-practice look at the funding of biopharmaceutical R&D. I approach its writing from the perspective that for the most part good theory leads to good practice and policy which should lead to better outcomes, notably the development of innovative drugs and therapeutics. The majority of the book is spent discussing the history, trends, and mechanics related to financing biopharmaceutical R&D and linking this to their multiple theoretical contexts. I borrow heavily from the economics, entrepreneurship, finance, innovation, and strategic management literatures, synthesizing and ...